ICD-10-CM & ICD-10-PCS (2025)-ICD-10-CM: Diseases and Injuries (2025)-ICD-10-CM: Drugs and Chemicals (2025)-ICD-10-CM: External Cause of Injuries (2025)-ICD-10-PCS (2025)ICD-10-CM & ICD-10-PCS (2024)-ICD-10-CM: Diseases and Injuries (2024)-ICD-10-CM: Drugs and Chemicals (2024)-ICD-10-CM: External Cause of Injuries (2024)-ICD-10-PCS (2024)ICD-10-CM & ICD-10-PCS (2023)-ICD-10-CM: Diseases and Injuries (2023)-ICD-10-CM: Drugs and Chemicals (2023)-ICD-10-CM: External Cause of Injuries (2023)-ICD-10-PCS (2023)ICD-10-CM & ICD-10-PCS (2022)-ICD-10-CM: Diseases and Injuries (2022)-ICD-10-CM: Drugs and Chemicals (2022)-ICD-10-CM: External Cause of Injuries (2022)-ICD-10-PCS (2022)ICD-10-CM & ICD-10-PCS (2021)-ICD-10-CM: Diseases and Injuries (2021)-ICD-10-CM: Drugs and Chemicals (2021)-ICD-10-CM: External Cause of Injuries (2021)-ICD-10-PCS (2021)ICD-10-CM & ICD-10-PCS (2020)-ICD-10-CM: Diseases and Injuries (2020)-ICD-10-CM: Drugs and Chemicals (2020)-ICD-10-CM: External Cause of Injuries (2020)-ICD-10-PCS (2020)ICD-10-CM & ICD-10-PCS (2019)-ICD-10-CM: Diseases and Injuries (2019)-ICD-10-CM: Drugs and Chemicals (2019)-ICD-10-CM: External Cause of Injuries (2019)-ICD-10-PCS (2019)ICD-10-CM & ICD-10-PCS (2018)-ICD-10-CM: Diseases and Injuries (2018)-ICD-10-CM: Drugs and Chemicals (2018)-ICD-10-CM: External Cause of Injuries (2018)-ICD-10-PCS (2018)ICD-10-CM & ICD-10-PCS (2017)-ICD-10-CM: Diseases and Injuries (2017)-ICD-10-CM: Drugs and Chemicals (2017)-ICD-10-CM: External Cause of Injuries (2017)-ICD-10-PCS (2017)ICD-10-CM & ICD-10-PCS (2016)-ICD-10-CM: Diseases and Injuries (2016)-ICD-10-CM: Drugs and Chemicals (2016)-ICD-10-CM: External Cause of Injuries (2016)-ICD-10-PCS (2016) Create codetable from scratch         Contact

Mastocytosis D47.09
    aggressive systemic C96.21
    cutaneous (diffuse) (maculopapular) D47.01
        congenital Q82.2
        of neonatal onset Q82.2
        of newborn onset Q82.2
    indolent systemic D47.02
    isolated bone marrow D47.02
    malignant C96.29
    systemic (indolent) (smoldering)
        with an associated hematological non-mast cell lineage disease (SM-AHNMD) D47.02